Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors.
Jorge Enrique Machado-AlbaManuel Enrique Machado-DuqueAndrés Gaviria-MendozaI N Arsof-SaabC A Castellanos-MorenoL BoteroL TrianaPublished in: Journal of endocrinological investigation (2022)
Patients with acromegaly and neuroendocrine tumors in Colombia are mainly women and are most frequently treated with lanreotide autogel for acromegaly and with octreotide LAR for neuroendocrine tumors. In addition, a high proportion are managed with maximum doses of long-acting somatostatin analogs.